Therapeutics in the Treatment of COVID-19 for Children and Adolescents
- Author:
Soo-Han CHOI
1
;
Jae Hong CHOI
;
Ki Wook YUN
Author Information
- Publication Type:Review
- From:Pediatric Infection & Vaccine 2022;29(1):1-15
- CountryRepublic of Korea
- Language:English
- Abstract: Coronavirus disease 2019 (COVID-19) presents as a mild-to-moderate respiratory illness in most children. However, a small proportion of children with COVID-19 develop severe or critical illnesses. Although pediatric clinical trials for the treatment of COVID-19 are sparse, some drugs are available for children and adolescents with severe COVID-19. This review summarizes clinical data focusing on antiviral agents and immunomodulators for use in treating COVID-19. In addition, current recommendations for therapeutics for children and adolescents with COVID-19 are discussed.
